Cargando…
Clinical and radiological evidence of the recurrence of reversible pegvisomant-related lipohypertrophy at the new site of injection in two women with acromegaly: a case series
INTRODUCTION: Pegvisomant-related lipohypertrophy may revert when changing the site of injection, but the lipohypertrophy may recur at the new site of injection. The strength of evidence, however, is weak and comes from information obtained from physical examination only. CASE PRESENTATION: We studi...
Autores principales: | Rochira, Vincenzo, Zirilli, Lucia, Diazzi, Chiara, Romano, Stefania, Carani, Cesare |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398337/ https://www.ncbi.nlm.nih.gov/pubmed/22233881 http://dx.doi.org/10.1186/1752-1947-6-2 |
Ejemplares similares
-
The osteoporotic male: Overlooked and undermanaged?
por: Madeo, Bruno, et al.
Publicado: (2007) -
Pegvisomant in acromegaly: an update
por: Giustina, A., et al.
Publicado: (2017) -
Premature Decline of Serum Total Testosterone in HIV-Infected Men in the HAART-Era
por: Rochira, Vincenzo, et al.
Publicado: (2011) -
Nanomedicines in the treatment of acromegaly: focus on pegvisomant
por: Roelfsema, Ferdinand, et al.
Publicado: (2006) -
Pegvisomant for acromegaly: does it always works?
por: Neggers, Sebastian J., et al.
Publicado: (2019)